ITRI vs PODD · P/E 13, rev $2.44B vs P/E 34, rev $2.07B
Itron Inc (ITRI) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Itron Inc (ITRI) is a scientific & technical instruments company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported ITRI revenue for 2024-12-31 was $2.44B. Net income was $241.1M. Revenue was up 12.3% from 2023-12-31 to 2024-12-31. ITRI currently screens at market cap $3.64B and trailing P/E 13.1.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
ITRI currently screens at market cap $3.64B and trailing P/E 13.1. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the ITRI and PODD stock pages for the full models.
Not investment advice.